SlideShare a Scribd company logo
1 of 21
Medications Return Programs http:// www.medicationsreturn.ca / Post-Consumer Pharmaceutical Stewardship Association PCPSA
[object Object],[object Object],[object Object],[object Object],Outline
[object Object],[object Object],[object Object],[object Object],History
[object Object],[object Object],[object Object],Guiding  Principles
Guiding  Principles (con’t) ,[object Object],[object Object]
Management Roles ,[object Object],[object Object],[object Object],[object Object],[object Object]
MRP Approach ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MRP Approach ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MRP Review ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medications Return Program ,[object Object],[object Object],[object Object]
Medications Return Program ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],Medications Return Program
Medications Return Program ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],Medications Return Program
Containers
Medications Return Program ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medications Return Program ,[object Object],[object Object],[object Object],[object Object]
Challenges ,[object Object],[object Object],[object Object],[object Object],[object Object]
Challenges ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Provincial Programs
Questions? Ginette Vanasse Executive Director PCPSA www.medicaitonsreturn.ca [email_address] May 2010

More Related Content

What's hot

Getting In Control Of Health Care Costs
Getting In Control Of Health Care CostsGetting In Control Of Health Care Costs
Getting In Control Of Health Care CostsCKiskaden
 
How to Strengthen Your API Supply Chain Management and Sourcing
How to Strengthen Your API Supply Chain Management and SourcingHow to Strengthen Your API Supply Chain Management and Sourcing
How to Strengthen Your API Supply Chain Management and SourcingSaharsh Davuluri
 
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel   collab formulary hospital-public plan - eric lun finalCadth 2015 c6 panel   collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun finalCADTH Symposium
 
Design and Implementation for HARPC
Design and Implementation for HARPCDesign and Implementation for HARPC
Design and Implementation for HARPCAudioEducator
 
Pricing strategy poland
Pricing strategy polandPricing strategy poland
Pricing strategy polandAmy Morgan
 
Presentation: Improving the regulation of generic medicines in Australia
Presentation: Improving the regulation of generic medicines in AustraliaPresentation: Improving the regulation of generic medicines in Australia
Presentation: Improving the regulation of generic medicines in AustraliaTGA Australia
 
Lone Star Co Pay Meds General Overview
Lone Star Co Pay Meds General OverviewLone Star Co Pay Meds General Overview
Lone Star Co Pay Meds General OverviewPam Cook
 
Pharmacovigilance (gpv p) training in india
Pharmacovigilance (gpv p) training in india Pharmacovigilance (gpv p) training in india
Pharmacovigilance (gpv p) training in india Radhika Nagare
 
Utilization of Medical Devices Standards to Demonstrate Safety
Utilization of Medical Devices Standards to Demonstrate SafetyUtilization of Medical Devices Standards to Demonstrate Safety
Utilization of Medical Devices Standards to Demonstrate SafetyUN SPHS
 
Comprehensive pharmacy services | Point of care
Comprehensive pharmacy services | Point of careComprehensive pharmacy services | Point of care
Comprehensive pharmacy services | Point of caredanielbrain10
 
Facts about Compounding Pharmacies and Accreditation_12-15-2014
Facts about Compounding Pharmacies and Accreditation_12-15-2014Facts about Compounding Pharmacies and Accreditation_12-15-2014
Facts about Compounding Pharmacies and Accreditation_12-15-2014Jackie Mlagan
 
Presentation: Advertising therapeutic goods to consumers
Presentation: Advertising therapeutic goods to consumers Presentation: Advertising therapeutic goods to consumers
Presentation: Advertising therapeutic goods to consumers TGA Australia
 

What's hot (13)

Getting In Control Of Health Care Costs
Getting In Control Of Health Care CostsGetting In Control Of Health Care Costs
Getting In Control Of Health Care Costs
 
How to Strengthen Your API Supply Chain Management and Sourcing
How to Strengthen Your API Supply Chain Management and SourcingHow to Strengthen Your API Supply Chain Management and Sourcing
How to Strengthen Your API Supply Chain Management and Sourcing
 
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel   collab formulary hospital-public plan - eric lun finalCadth 2015 c6 panel   collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
 
Design and Implementation for HARPC
Design and Implementation for HARPCDesign and Implementation for HARPC
Design and Implementation for HARPC
 
Pricing strategy poland
Pricing strategy polandPricing strategy poland
Pricing strategy poland
 
Presentation: Improving the regulation of generic medicines in Australia
Presentation: Improving the regulation of generic medicines in AustraliaPresentation: Improving the regulation of generic medicines in Australia
Presentation: Improving the regulation of generic medicines in Australia
 
Lone Star Co Pay Meds General Overview
Lone Star Co Pay Meds General OverviewLone Star Co Pay Meds General Overview
Lone Star Co Pay Meds General Overview
 
Pharmacovigilance (gpv p) training in india
Pharmacovigilance (gpv p) training in india Pharmacovigilance (gpv p) training in india
Pharmacovigilance (gpv p) training in india
 
Utilization of Medical Devices Standards to Demonstrate Safety
Utilization of Medical Devices Standards to Demonstrate SafetyUtilization of Medical Devices Standards to Demonstrate Safety
Utilization of Medical Devices Standards to Demonstrate Safety
 
Comprehensive pharmacy services | Point of care
Comprehensive pharmacy services | Point of careComprehensive pharmacy services | Point of care
Comprehensive pharmacy services | Point of care
 
Pharmacy savings2
Pharmacy savings2Pharmacy savings2
Pharmacy savings2
 
Facts about Compounding Pharmacies and Accreditation_12-15-2014
Facts about Compounding Pharmacies and Accreditation_12-15-2014Facts about Compounding Pharmacies and Accreditation_12-15-2014
Facts about Compounding Pharmacies and Accreditation_12-15-2014
 
Presentation: Advertising therapeutic goods to consumers
Presentation: Advertising therapeutic goods to consumers Presentation: Advertising therapeutic goods to consumers
Presentation: Advertising therapeutic goods to consumers
 

Similar to 6 pcpsa bc vanasse

Control of Pharmaceuticals at DHMC
Control of Pharmaceuticals at DHMCControl of Pharmaceuticals at DHMC
Control of Pharmaceuticals at DHMCMark Campanale
 
The Importance of Drug Take-back Programs: Protecting our Health and Environment
The Importance of Drug Take-back Programs: Protecting our Health and EnvironmentThe Importance of Drug Take-back Programs: Protecting our Health and Environment
The Importance of Drug Take-back Programs: Protecting our Health and EnvironmentSuzy Whalen
 
The Importance of Drug Take-back Programs: Protecting our Health and Environment
The Importance of Drug Take-back Programs: Protecting our Health and EnvironmentThe Importance of Drug Take-back Programs: Protecting our Health and Environment
The Importance of Drug Take-back Programs: Protecting our Health and EnvironmentThe Product Stewardship Institute
 
Segregation Training_New Incineration Requirements (10-12).pdf
Segregation Training_New Incineration Requirements (10-12).pdfSegregation Training_New Incineration Requirements (10-12).pdf
Segregation Training_New Incineration Requirements (10-12).pdfgursimratsingh20
 
5.5. State Regulations and Guidance (Batz)
5.5. State Regulations and Guidance (Batz)5.5. State Regulations and Guidance (Batz)
5.5. State Regulations and Guidance (Batz)Teleosis Institute
 
CleanMed 2017
CleanMed 2017CleanMed 2017
CleanMed 2017UN SPHS
 
2program highlights may 2010 gloyd
2program highlights may 2010 gloyd2program highlights may 2010 gloyd
2program highlights may 2010 gloydSteve Brachman
 
Helping Pharmas Manage Compliance Risks for Speaker Programs
Helping Pharmas Manage Compliance Risks for Speaker ProgramsHelping Pharmas Manage Compliance Risks for Speaker Programs
Helping Pharmas Manage Compliance Risks for Speaker ProgramsCognizant
 
3.5. Facts About Disposal in the U.S. (Kreisberg)
3.5. Facts About Disposal in the U.S. (Kreisberg)3.5. Facts About Disposal in the U.S. (Kreisberg)
3.5. Facts About Disposal in the U.S. (Kreisberg)Teleosis Institute
 
UNDP Sustainable Health Procurement Policy and Practice
UNDP Sustainable Health Procurement Policy and PracticeUNDP Sustainable Health Procurement Policy and Practice
UNDP Sustainable Health Procurement Policy and PracticeUN SPHS
 
2011June PharmaceuticalMarketEurope ValuableCollection
2011June PharmaceuticalMarketEurope ValuableCollection2011June PharmaceuticalMarketEurope ValuableCollection
2011June PharmaceuticalMarketEurope ValuableCollectionAleksandar Ruzicic
 
Private Insurance Plans - Do they have a future in Canada?
Private Insurance Plans - Do they have a future in Canada?Private Insurance Plans - Do they have a future in Canada?
Private Insurance Plans - Do they have a future in Canada?Canadian Cancer Survivor Network
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics academic
 

Similar to 6 pcpsa bc vanasse (20)

Control of Pharmaceuticals at DHMC
Control of Pharmaceuticals at DHMCControl of Pharmaceuticals at DHMC
Control of Pharmaceuticals at DHMC
 
The Importance of Drug Take-back Programs: Protecting our Health and Environment
The Importance of Drug Take-back Programs: Protecting our Health and EnvironmentThe Importance of Drug Take-back Programs: Protecting our Health and Environment
The Importance of Drug Take-back Programs: Protecting our Health and Environment
 
The Importance of Drug Take-back Programs: Protecting our Health and Environment
The Importance of Drug Take-back Programs: Protecting our Health and EnvironmentThe Importance of Drug Take-back Programs: Protecting our Health and Environment
The Importance of Drug Take-back Programs: Protecting our Health and Environment
 
Segregation Training_New Incineration Requirements (10-12).pdf
Segregation Training_New Incineration Requirements (10-12).pdfSegregation Training_New Incineration Requirements (10-12).pdf
Segregation Training_New Incineration Requirements (10-12).pdf
 
Magazine Sample 1
Magazine Sample 1Magazine Sample 1
Magazine Sample 1
 
Green pharmacy.pptx
Green pharmacy.pptxGreen pharmacy.pptx
Green pharmacy.pptx
 
5.5. State Regulations and Guidance (Batz)
5.5. State Regulations and Guidance (Batz)5.5. State Regulations and Guidance (Batz)
5.5. State Regulations and Guidance (Batz)
 
CleanMed 2017
CleanMed 2017CleanMed 2017
CleanMed 2017
 
Disposal of unused medicines
Disposal of unused medicinesDisposal of unused medicines
Disposal of unused medicines
 
2program highlights may 2010 gloyd
2program highlights may 2010 gloyd2program highlights may 2010 gloyd
2program highlights may 2010 gloyd
 
Specialty one pager FINAL
Specialty one pager FINALSpecialty one pager FINAL
Specialty one pager FINAL
 
Cp documentation
Cp documentationCp documentation
Cp documentation
 
Helping Pharmas Manage Compliance Risks for Speaker Programs
Helping Pharmas Manage Compliance Risks for Speaker ProgramsHelping Pharmas Manage Compliance Risks for Speaker Programs
Helping Pharmas Manage Compliance Risks for Speaker Programs
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
 
3.5. Facts About Disposal in the U.S. (Kreisberg)
3.5. Facts About Disposal in the U.S. (Kreisberg)3.5. Facts About Disposal in the U.S. (Kreisberg)
3.5. Facts About Disposal in the U.S. (Kreisberg)
 
UNDP Sustainable Health Procurement Policy and Practice
UNDP Sustainable Health Procurement Policy and PracticeUNDP Sustainable Health Procurement Policy and Practice
UNDP Sustainable Health Procurement Policy and Practice
 
2011June PharmaceuticalMarketEurope ValuableCollection
2011June PharmaceuticalMarketEurope ValuableCollection2011June PharmaceuticalMarketEurope ValuableCollection
2011June PharmaceuticalMarketEurope ValuableCollection
 
Private Insurance Plans - Do they have a future in Canada?
Private Insurance Plans - Do they have a future in Canada?Private Insurance Plans - Do they have a future in Canada?
Private Insurance Plans - Do they have a future in Canada?
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 

More from Steve Brachman

5 mpsc who we are moore
5 mpsc who we are moore5 mpsc who we are moore
5 mpsc who we are mooreSteve Brachman
 
Program highlights may 2010 gloyd
Program highlights may 2010 gloydProgram highlights may 2010 gloyd
Program highlights may 2010 gloydSteve Brachman
 
7 medicinereturninitiativesinwa shield
7 medicinereturninitiativesinwa shield7 medicinereturninitiativesinwa shield
7 medicinereturninitiativesinwa shieldSteve Brachman
 
4 fletcher presentation get the meds out 5 18-10
4 fletcher presentation get the meds out 5 18-104 fletcher presentation get the meds out 5 18-10
4 fletcher presentation get the meds out 5 18-10Steve Brachman
 
3 brachman educational and outreach resources
3 brachman educational and outreach resources3 brachman educational and outreach resources
3 brachman educational and outreach resourcesSteve Brachman
 
1 kohrell wi overview get the old meds out workshop 5 19 2010
1 kohrell wi overview get the old meds out workshop 5 19 20101 kohrell wi overview get the old meds out workshop 5 19 2010
1 kohrell wi overview get the old meds out workshop 5 19 2010Steve Brachman
 

More from Steve Brachman (6)

5 mpsc who we are moore
5 mpsc who we are moore5 mpsc who we are moore
5 mpsc who we are moore
 
Program highlights may 2010 gloyd
Program highlights may 2010 gloydProgram highlights may 2010 gloyd
Program highlights may 2010 gloyd
 
7 medicinereturninitiativesinwa shield
7 medicinereturninitiativesinwa shield7 medicinereturninitiativesinwa shield
7 medicinereturninitiativesinwa shield
 
4 fletcher presentation get the meds out 5 18-10
4 fletcher presentation get the meds out 5 18-104 fletcher presentation get the meds out 5 18-10
4 fletcher presentation get the meds out 5 18-10
 
3 brachman educational and outreach resources
3 brachman educational and outreach resources3 brachman educational and outreach resources
3 brachman educational and outreach resources
 
1 kohrell wi overview get the old meds out workshop 5 19 2010
1 kohrell wi overview get the old meds out workshop 5 19 20101 kohrell wi overview get the old meds out workshop 5 19 2010
1 kohrell wi overview get the old meds out workshop 5 19 2010
 

6 pcpsa bc vanasse

Editor's Notes

  1. Canada's Research-Based Pharmaceutical Companies Canadian Generic Pharmaceutical Association, Consumer Health Products Canada
  2. PCPSA Guiding Principles for Developing a National Program Level Playing field Both the Recycling Regulation and the PCPSA stewardship plan include mechanisms designed to minimize the number of obligated producers not participating in the program. Shared Responsibilities Local, provincial and federal governments, consumers and other stakeholders should be responsible for maximizing the use of existing waste management infrastructure. Industry should be responsible for pickup and recycling. Post-Consumer waste stream The Pharmaceutical Category schedule of the Regulation and the PCPSA program are designed to deal with products in the consumer waste stream.
  3. Economic and environmental efficiency The PCPSA program is designed to establish benchmarks for both activities. Environmental management The PCPSA program meets this standard.
  4. See info
  5. We have achieved a 95% participation rate from community pharmacies. We monitor closures and opening to ensure awareness of Medications Return Program. We provided pharmacy managers with information to educate their staff on this program. We publish e-bulletin to communicate results and special events (med campaign) taking place in their province
  6. All prescription drugs and oral dosage from for over-the-counter medications and natural health products. Examples of dosage forms are: solids, semi-solids and powders caplets, capsules, tablets, granules, mixtures, powders for injection, creams, lotions, gels, suppositories, etc. liquids solutions, suspensions, syrups, ampoules, etc. aerosol canisters sprays and inhalers Novel dosage forms Strips, gums, patches, etc
  7. Excluding food and beverages products Including medicated patches, anti-bacterial and anti-fungus medications
  8. Track containers by original, weight and dates
  9. 5 gallons/ max 50 pounds Locking lids with 3 or 5 each openings Screw top pails and ties to secure lids, may need 3 levels of containment Re-usable containers with lining. Mail-back Drugs are not considered to attract theft since most are “average prescriptions” of no interest to abusers Track mix of drugs collected every 3 years in order to invoice the stewards by market share (generic/research based/OTC) Medications collected in BC Program 2009 50 tons or 110, 231 pounds
  10. The program is very simple, from the drop-off point used by consumers, through the collection at pharmacies by courier, to the secure storage and shipment for safe disposal. Track mix of drugs collected every 3 years in order to invoice the stewards by market share (generic/research based/OTC)
  11. Single regulation best, offers some flexibility. Special waste/prescribe waste category Medications has been approved and is safe for human when use as prescribed Safety issue, need to remove unused or expired meds from household rather than an environmental issue such as paint or pesticides.
  12. The bulk of human pharmaceuticals found in waterways most likely got there by way of sewage. Taking unused pharmaceuticals out of landfills may make only a small difference in the concentrations of APIs found in water. But take-back programs may help prevent leftover pharmaceuticals from being misused. For that reason and others, utilities and local governments are moving forward with a variety of pharmaceutical take-back efforts in the absence of regulations—or data indicating such programs actually work.